- Home
- PCB vs ZURA Comparison
PCB vs ZURA Comparison
Compare PCB & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCB
- ZURA
- Stock Information
- Founded
- PCB 2003
- ZURA 2022
- Country
- PCB United States
- ZURA United States
- Employees
- PCB N/A
- ZURA N/A
- Industry
- PCB Major Banks
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PCB Finance
- ZURA Health Care
- Exchange
- PCB Nasdaq
- ZURA Nasdaq
- Market Cap
- PCB 308.8M
- ZURA 69.9M
- IPO Year
- PCB N/A
- ZURA N/A
- Fundamental
- Price
- PCB $21.74
- ZURA $1.31
- Analyst Decision
- PCB Hold
- ZURA Buy
- Analyst Count
- PCB 2
- ZURA 7
- Target Price
- PCB $22.00
- ZURA $14.33
- AVG Volume (30 Days)
- PCB 31.8K
- ZURA 708.2K
- Earning Date
- PCB 07-24-2025
- ZURA 08-08-2025
- Dividend Yield
- PCB 3.67%
- ZURA N/A
- EPS Growth
- PCB 11.00
- ZURA N/A
- EPS
- PCB 1.94
- ZURA N/A
- Revenue
- PCB $98,720,000.00
- ZURA N/A
- Revenue This Year
- PCB $20.22
- ZURA N/A
- Revenue Next Year
- PCB $9.25
- ZURA N/A
- P/E Ratio
- PCB $11.25
- ZURA N/A
- Revenue Growth
- PCB 5.07
- ZURA N/A
- 52 Week Low
- PCB $15.45
- ZURA $0.97
- 52 Week High
- PCB $22.37
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- PCB 62.04
- ZURA 59.63
- Support Level
- PCB $21.84
- ZURA $1.00
- Resistance Level
- PCB $22.21
- ZURA $1.45
- Average True Range (ATR)
- PCB 0.45
- ZURA 0.10
- MACD
- PCB 0.08
- ZURA 0.03
- Stochastic Oscillator
- PCB 76.49
- ZURA 68.89
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.